STRATA Skin Sciences (SSKN) EBIT Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 67.06% |
| Sep 30, 2025 | -0.21% |
| Jun 30, 2025 | -7.42% |
| Mar 31, 2025 | -12.46% |
| Dec 31, 2024 | -32.05% |
| Sep 30, 2024 | -17.10% |
| Jun 30, 2024 | 13.43% |
| Mar 31, 2024 | -18.40% |
| Dec 31, 2023 | -28.05% |
| Sep 30, 2023 | -10.70% |
| Jun 30, 2023 | -9.99% |
| Mar 31, 2023 | -8.75% |
| Dec 31, 2022 | 16.68% |
| Sep 30, 2022 | -8.95% |
| Jun 30, 2022 | -65.44% |
| Mar 31, 2022 | -29.80% |
| Dec 31, 2021 | -28.76% |
| Sep 30, 2021 | -2.80% |
| Jun 30, 2021 | 8.74% |
| Mar 31, 2021 | -2.27% |
| Dec 31, 2020 | 25.32% |
| Sep 30, 2020 | 12.95% |
| Jun 30, 2020 | 29.09% |
| Mar 31, 2020 | 23.56% |
| Dec 31, 2019 | 20.92% |
| Sep 30, 2019 | 28.86% |
| Jun 30, 2019 | 25.41% |
| Mar 31, 2019 | 23.49% |
| Dec 31, 2018 | 20.50% |
| Sep 30, 2018 | 43.10% |
| Jun 30, 2018 | 29.57% |
| Mar 31, 2018 | 23.49% |
| Dec 31, 2017 | 32.95% |
| Sep 30, 2017 | 37.50% |
| Jun 30, 2017 | 15.21% |
| Mar 31, 2017 | 35.89% |
| Dec 31, 2016 | 15.88% |
| Sep 30, 2016 | 41.92% |
| Jun 30, 2016 | 21.30% |
| Mar 31, 2016 | 15.52% |
| Dec 31, 2015 | 23.02% |
| Sep 30, 2015 | 14.11% |
| Jun 30, 2015 | -14.37% |